GWMIA
CTSO icon

Global Wealth Management Investment Advisory’s Cytosorbents Corp CTSO Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150
Closed -$1K – 611
2020
Q1 		$1K Buy
+150
New +$757 ﹤0.01% 540
2019
Q2 		– Sell
-75
Closed -$1K – 706
2019
Q1 		$1K Sell
75
-538
-88% -$4.19K ﹤0.01% 606
2018
Q4 		$5K Buy
+613
New +$6.09K ﹤0.01% 481

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Wealth Management Investment Advisory's CTSO Position: Q2 2020 in Review

Global Wealth Management Investment Advisory sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 150 shares — an estimated $1K sold.

Global Wealth Management Investment Advisory first reported a position in CTSO in Q4 2018 and held it in 3 quarters. The position peaked at $5K in Q4 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Global Wealth Management Investment Advisory reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 150 Cytosorbents Corp shares in Q2 2020, an estimated $1K.
  • Global Wealth Management Investment Advisory first reported a position in Cytosorbents Corp in Q4 2018 and held it in 3 quarters.
  • Global Wealth Management Investment Advisory's Cytosorbents Corp position peaked at $5K in Q4 2018.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.